Real-world treatment patterns and characteristics of patients with diffuse large B-cell lymphoma (DLBCL): a retrospective analysis of US commercial and Medicare claims (2017-2024).

Saved in:
Bibliographic Details
Title: Real-world treatment patterns and characteristics of patients with diffuse large B-cell lymphoma (DLBCL): a retrospective analysis of US commercial and Medicare claims (2017-2024).
Authors: Phillips T; City of Hope Medical Center, Duarte, CA, USA., Zhou Z; Genesis Research Group, Hoboken, NJ, USA., Gutierrez C; Genesis Research Group, Hoboken, NJ, USA., Shao A; Genesis Research Group, Hoboken, NJ, USA., Boyd M; Genesis Research Group, Hoboken, NJ, USA., Noshad S; Genesis Research Group, Hoboken, NJ, USA., Hohlbauch A; Genesis Research Group, Hoboken, NJ, USA., Liu N; Pfizer, New York, NY, USA., Repetny K; Pfizer, New York, NY, USA., Fanale M; Pfizer, New York, NY, USA., Mitchell B; Pfizer, New York, NY, USA., Davis EA; Cencora, Conshohocken, PA, USA., Gennarelli R; Cencora, Conshohocken, PA, USA., Burke JM; Sarah Cannon Research Institute and Rocky Mountain Cancer Centers, Aurora, CO, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Feb; Vol. 67 (3), pp. 627-637. Date of Electronic Publication: 2026 Jan 19.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1029-2403
DOI:10.1080/10428194.2025.2604300